TLR2 and TLR4 are crucial for recognition of Chlamydia pneumoniae in vivo, since infected TLR2/4 double-deficient mice are unable to control the infection as evidenced by severe loss of body weight and progressive lethal pneumonia. Unexpectedly, these mice display higher pulmonary levels of the protective cytokine IFNc than wild type mice. We show here, that antigen-specific CD4
Introduction
The obligate intracellular bacterium Chlamydia pneumoniae infects the respiratory tract and replicates in bronchial epithelial cells [1, 2] . The cells are infected by elementary bodies of C. pneumoniae which develop within hours post infectionem into reticulate bodies [1] . The latter form divides several times and within 48 to 72 h a microscopically visible intracellular inclusion is generated. In vitro, the replication of C. pneumoniae is impaired by IFNc [3, 4] . This cytokine exerts its effect indirectly via the induction of two enzymes: the inducible isoform of the nitric oxide synthase (iNOS) and indolamine 2,3 dioxygenase (IDO). The former enzyme generates nitric oxide (NO), which is toxic for bacteria and impairs replication of C. pneumoniae [5] , while the latter degrades the aminoacid tryptophan, which is required by C. pneumoniae [6] . In vivo, the replication of the bacterium is also controlled by IFNc, as chlamydial burden in IFNc receptor-deficient mice is significantly higher than in wild type mice [7] . Based on these findings it is obvious that IFNc is crucial to control and confine pneumonia caused by C. pneumoniae.
The cellular source of IFNc in vivo during pulmonary infection with C. pneumoniae was analyzed by Rothfuchs et al [8] . Accordingly, NK cells neither contributed to IFNc-secretion by bronchoalveolar lavage mononuclear cells nor protected mice. In contrast, IFNc-secreting CD4 + or CD8 + T-cells were protective since they impaired replication of C. pneumoniae. Thus, IFNcsecreting cells of the adaptive immune system contribute to host defense against the bacterium.
Innate immune cells like bone marrow derived dendritic (BMDC) cells recognize C. pneumoniae via TLR2 and 4 [9] . In contrast to wild type animals, mice double-deficient for TLR2 and 4 were unable to control the replication of the bacteria and succumbed to progressive pneumonia [10] . Moreover, although many immune responses in vivo, such as the secretion of proinflammatory cytokines and chemokines, depended almost exclusively on TLR2, the survival of infected mice required the presence of TLR2 but also of TLR4 [10] . Unexpectedly, TLR2/4 double-deficient but not TLR2-deficient mice displayed upon infection with the microorganism significantly higher pulmonary levels of IFNc than wild type mice [10] .
TLRs also influence the adaptive immune response. Thus, mice lacking MyD88, the most important adapter molecule of the TLRsignaling cascade, failed to mount a TH1 response upon immunization with the model antigen ovalbumin in complete Freund's adjuvant while antigen-specific TH2 responses were not impaired [11] . In particular, antigen-specific T-cells from MyD88-deficient mice were unable to produce IFNc, but secreted TH2 cytokines like IL-13 and IL-4 at least as efficiently as T-cells from wild type mice. Likewise, it was shown that endotoxin-stimulated wild type dendritic cells induced allogeneic CD4
+ T-cells to secrete IFNc while MyD88-deficient allogenic dendritic cells only stimulated a TH2 response [12] . However, upon vaccination of MyD88-deficient mice with Mycobacterium bovis BCG a TH1 response was observed as in wild type mice [13] . Interestingly, the adaptive immune response induced by the vaccination was only partially effective to prevent the lethal outcome of a challenging Mycobacterium tuberculosis infection in MyD88-deficient mice. In summary, the influence of MyD88 on adaptive immune responses appears to depend substantially from the model system used.
Here, we explored adaptive immune responses in mice lacking TLR2 and TLR4 upon pulmonary infection with C. pneumoniae. The results demonstrate that an increased IFNc-release by the adaptive immune system in the absence of both TLRs was associated with a lower frequency of regulatory T-cells. However, the cytokine was unable to trigger the release of NO by TLR2/4 double-deficient bone marrow-derived macrophages (BMDM). The latter finding presumably contributes to the increased lethality observed in TLR2/4 double-deficient mice.
Results

Pulmonary recruitment of T-cells was not impaired in TLR2/4 double-deficient mice
To explore whether adaptive immune responses were induced in vivo in the absence of TLR2 and 4 known to be of key importance for the recognition of C. pneumoniae, we infected wild type and TLR2/4 double-deficient mice pulmonary with C. pneumoniae. As shown in Fig. 1 these TLR-deficient mice lost a considerable part of their body weight between day 9 and day 12 post infection. In contrast, this was not observed in wild type mice which displayed a weaker weight loss between day 0 and 9. Similar data were demonstrated previously and that study also showed that the TLR2/4 double-deficient mice succumbed to the infection [10] . While recruitment of polymorphonuclear neutrophils into the infected lungs was considerably impaired in TLR2/4 doubledeficient mice [10] , CD4
+ and CD8 + T-cells were present in wild type and TLR2/4 double-deficient mice in similar numbers ( Fig. 2A, B) .
Presence of CD4
+ IFNc + T-cells in the lung of TLR2/4 double-deficient mice
To study whether C. pneumoniae-specific T-cells were detectable in the infected lung of TLR2/4 double deficient mice, we restimulated T-cells isolated from the lung of infected animals with wild type BMDC in vitro, which were either infected or not infected with C. pneumoniae. Intracellular staining for IFNc revealed that the frequency and absolute number of CD4 + T-cells producing the cytokine upon re-stimulation with C. pneumoniae were higher in TLR2/4 double-deficient when compared to wild type mice especially day 9 post infection ( Fig. 3A, B) . Compared to CD4
+ IFNc + T-cells, the frequency and absolute number of IFNc-secreting CD8 + T-cells were considerably lower in both + T-Cells strains of mice (Fig. 3B) . However, on day 9 these cells were also enhanced in frequency in the infected TLR2/4 double-deficient mice. Furthermore, IFNc-secretion by CD4 + but CD3 2 non Tcells was barely detectable (Fig. 3C) . These results suggested that antigen-specific TH1 T-cell responses were efficiently generated in the absence of TLR2 and 4.
Enhanced Chlamydia-specific IFNc-responses in the absence of TLR2/4 is not confined to the lung Next, we assessed the local and systemic IFNc-responses from lung and spleen cells of infected wild type or TLR2/4 doubledeficient mice upon re-stimulation in vitro with C. pneumoniae-pulsed wild type BMDC. The results revealed that antigen-specific responses from lung and spleen cells isolated from infected TLR2/ 4 double-deficient mice secreted considerably more IFNc than wild type cells after 3 days in culture (Fig. 4) . These findings also suggested that increased responses by TLR2/4 double-deficient cells were not confined to the organ infected primarily.
TLR2/4 double-deficient BMDC are capable of stimulating antigen-specific IFNc-responses
We then explored the capacity of TLR2/4 double-deficient BMDC to trigger an IFNc response by C. pneumoniae-specific lung cells. We expected a weaker ability since activation of TLR2-deficient BMDC upon infection with the bacterium in vitro was impaired as analyzed by IL-12p40 and TNF secretion and induction of NF-kB [9] . In vivo, however, the infection induced the expression of the co-stimulatory molecules CD86 and CD80 as well as MHC class II by CD11c + cells in wild type and TLR2/4 double-deficient mice with comparable efficiency (Fig. 5A, B) . Based on the data presented in Fig. 3 we conclude that TLR2/4 double-deficient antigen-presenting cells triggered primary CD4 + T cells at least as efficiently as wild type cells. In addition, C. pneumoniae-infected TLR2/4 double-deficient BMDC re-stimulated lung cells, which were isolated from C. pneumoniae-infected wild type mice, as efficiently as wild type BMDC to secrete IFNc (Fig. 5C ). We therefore conclude that a deficiency of TLR2 and TLR4 by BMDCs did not explain the stronger IFNc-response of antigen-specific T-cells.
Lungs of TLR2/4 double-deficient mice contain fewer CD4
+ CD25 + Foxp3 + regulatory T-cells upon infection with C. pneumoniae Several reports indicated that TLR2 influences the expansion and function of regulatory T-cells and express TLR2 on their cell surface upon activation with anti CD3 [14] . Additionally, costimulation with the TLR2-ligand Pam3Cys has been shown to induce their proliferation which is accompanied by a transient loss of their suppressive activity [14, 15] . In vivo, TLR2 was also shown to be crucial for the expansion of regulatory T-cells in mice infected with Schistosoma mansoni [16] . Therefore, we analyzed the frequency of CD4 
IFNc fails to induce iNOS in C. pneumoniae-infected TLR2/ 4 double-deficient BMDMs
Normally, CD4
+ IFNc + effector T-cells play a protective role during C. pneumoniae infection [8] . As demonstrated in Fig. 1 , TLR2/4 double deficient mice lost considerably more weight at day 12 post infection than wild type mice despite increased IFNc levels. We also demonstrated earlier that these mice displayed a higher lethality [10] . Therefore, we were interested in the effects of IFNc on anti-chlamydial defense and investigated the influence of IFNc on iNOS production in TLR2/4 double-deficient cells. This enzyme participates in the control of an infection with C. pneumoniae in vivo as revealed by the analysis of iNOS-deficient mice [7] . We also examined previously the role of MyD88, the adapter molecule used by TLR2 and TLR4, in the induction of iNOS and showed that the level of this enzyme was reduced in infected MyD88-deficient mice [17] . MyD88-deficient BMDM failed to release nitric oxide (NO) upon stimulation with C. pneumoniae and IFNc since two important transcription factors, NFkB and AP-1 which participate in the transcriptional regulation of the nos2 gene, were not induced, while induction of IRF-1 and phosphorylation of STAT-1 were normal [17] . As we show here, upon stimulation with IFNc IRF-1 induction is not affected in TLR2/4 double-deficient macrophages (Fig. 7A) . Moreover, prior infection of the macrophages with C. pneumoniae did not alter the ability of IFNc to induce IRF-1 in BMDM of both genotypes (Fig. 7A) . As expected, infection of BMDM with C. pneumoniae degraded IkB in wild type but not in TLR2/4 double-deficient cells (Fig. 7B) . Since NF-kB is crucial for the induction of iNOS [17] , it was not unexpected that the ability of IFNc to induce iNOS-expression was severely impaired in C. pneumoniae-infected TLR2/4 double-deficient BMDM (Fig. 7C) . Moreover, NOsecretion was completely abolished (Fig. 7D) . Taken together, the failure of IFNc to induce iNOS presumably contributes to lethality observed in TLR2/4 double-deficient mice.
Discussion
Using TLR2/4 double-deficient mice we show that TLR2 and TLR4 regulate IFNc-secretion in vivo during pneumonia caused by C. pneumoniae. Our findings demonstrate that CD4 + T-cells, the cytokine failed to induce NO by BMDM lacking TLR2 and TLR4.
Previous reports indicated that the TLR key adapter molecule MyD88 was required for a TH1 CD4
+ T-cell response upon stimulation of the cells with ovalbumin in complete Freund's adjuvant or by endotoxin plus allogeneic cells [11, 12] . Our results show, however, that in the absence of the relevant TLRs, i.e. TLR2 and TLR4, CD4
+ T-cells can be sensitized to release IFNc upon infection with C. pneumoniae. In agreement with the data presented here, infection of MyD88-deficient mice with Mycobacterium bovis BCG also triggered CD4
+ T-cells to produce IFNc [13] . While the reasons for these discrepancies are unclear, it is likely that MyD88-independent recognition systems including NOD-like receptors also recognize bacteria-derived ligands which are presumably not present in complete Freund's adjuvant or in endotoxin preparations. Based on our previous report, C. pneumoniae-induced secretion of the cytokines TNF and IFNc and the chemokines KC and MCP-1 depended on MyD88 three days post infection. However, six days post infection these cyto-and chemokines were secreted MyD88-independently [2] . Thus, we speculate that the complex composition of pathogen-associated molecular patterns of bacteria allows the MyD88-independent induction of a TH1-response.
TLR2/4 double-deficient BMDC re-stimulated wild type cells with the same efficiency as wild type BMDC to produce IFNc. Although TLR2-deficient BMDC were impaired to secrete TNF and IL-12p40 upon infection with C. pneumoniae in vitro [9] , both factors were presumably not required for T-cell stimulation. However, TLR4-deficient BMDC failed to increase the expression of the co-stimulatory cell surface molecule CD40 upon stimulation with endotoxin and were unable to stimulate allogeneic T-cells, while the endotoxin-induced up-regulation of CD40, CD80 and CD86 was independent from MyD88 [18] . Since the infection of TLR2/4 double-deficient mice with C. pneumoniae generated even more CD4
+ IFNc + T-cells, we conclude that in vivo antigenpresenting cells are not impaired in their ability to activate antigen-specific T-cells in the absence of TLR2 and TLR4.
Enhanced IFNc-responses by C. pneumoniae-specific CD4 + Tcells in TLR2/4 double-deficient mice are best explained by an impaired infection-associated expansion of CD4 + CD25
+
Foxp3
+ regulatory T-cells. In contrast to MyD88-deficient mice, which appear to contain reduced numbers of regulatory T-cells [15] , the frequency of these cells in mock-treated TLR2/4 double-deficient mice was similar to the one in wild type mice. Our results are in agreement with reports, which show that expansion of Tregs can be triggered by a co-stimulation of T-cell receptors and TLR2 [14, 15] . As we have published earlier, chlamydial heat shock protein 60 (HSP60, GroEL) triggers cells via TLR2 and TLR4 [19, 20, 21] and may (together with C. pneumoniae-derived antigens) Figure 5 . Antigen-presentation is not impaired in TLR2/4 double-deficient BMDC. In (A) and (B) lung cells were prepared three days post infection with C. pneumoniae. Our results also imply that the adaptive TH1 immune response is unable to prevent the lethal outcome of pulmonary infection caused by C. pneumoniae, if TLR2 and TLR4 are absent. In association, previous studies have shown the importance of IFNcproducing CD4
+ T-cells in increasing resistance of RAG-1/IFNcdouble-deficient mice against an infection with C. pneumoniae [8] . Similar observations were obtained in a model where MyD88-deficient mice were infected with M. tuberculosis. Vaccination of MyD88-deficient mice with M. bovis BCG induced IFNcproducing CD4
+ T-cells in vivo, but the TH1 cells only partially prevented lethal pneumonia upon challenge with M. tuberculosis [13] . Upon challenge with C. pneumoniae MyD88-deficient mice succumbed like TLR2/4-deficient mice to progressive pneumonia [10] , although pulmonary IFNc-levels were increased like in wild type mice six days post infection [2] . Furthermore, the ability of IFNc to induce iNOS was impaired in MyD88-deficient macrophages [17] . Full induction of iNOS required the transcription factors AP-1, NF-kB, IRF-1 and STAT-1. The former two were not activated in MyD88-deficient bone marrow-derived macrophages (BMDM) upon infection with C. pneumoniae in vitro leading to a complete failure to induce iNOS. In vivo, iNOS-levels were considerably reduced in MyD88-deficient mice post infection with C. pneumoniae. Identical to these published findings we show here, that in C. pneumoniae-infected TLR2/4 double-deficient BMDM IFNc only weakly up-regulated the expression of iNOS and failed to induce the secretion of NO, since the infection of these cells with C. pneumoniae did not induce NF-kB. INOS is crucial to control the replication of C. pneumoniae in vivo, since the chlamydial burden is considerably increased in iNOS-deficient mice [7] . Thus, although C. pneumoniae-specific CD4 + T-cells produce enhanced amounts of IFNc in TLR2/4-deficient mice, the cytokine cannot completely exert its protective effects in TLR2/4 double-deficient mice, since it is impaired to induce iNOS.
In summary, expansion of CD4 + CD25
+
Foxp3
+ T-cells is impaired in C. pneumoniae-infected TLR2/4 double-deficient mice. This is accompanied by an increased frequency of CD4 
Materials and Methods
Ethic statement
All animal experiments were reviewed and approved by the local authorities (Regierung von Oberbayern, file number 211-2531-59/06).
Strains of mice
C3H/HeN mice were purchased from Harlan Winkelmann GmbH (Borchen, Germany). Breeding pairs of C57BL/6 TLR2 2/2 mice came from Tularik (South San Francisco, CA). They were backcrossed six times to TLR4 d/d C3H/HeJ mice to generate TLR2/4 double-deficient mice. The genotype of the mice was verified phenotypically as described in [21] . Alternatively, TLR2 2/2 mice were crossed with TLR4 2/2 mice and the resulting TLR2/4 double-deficient mice were further backcrossed nine times to C3H/ HeN mice. The genotype of these mice was analyzed by PCR (Fig.  S1 ). All mice were bred in our own animal facility under specific pathogen-free conditions.
Reagents
The peroxidase-conjugated AffiniPure F(ab) 2 
Infection protocol
Anesthesized mice were infected intranasally with Chlamydia pneumoniae (CM-1, ATCC VR-1360, 2.5610 6 IFUs). Infected mice were inspected every day and body weight was determined on day 6 and 9 and 12 post infection.
Generation of BMDC and BMDM
BMDC were generated according to Inaba et al with slight modification [22] . Mice were sacrificed and tibiae and femora were removed, cleaned and flushed with cell culture medium. They were plated on bacterial petri-dishes overnight in culture medium (RPMI 1640, 10% heat-inactivated FCS, 100 mg/ml penicillin, 100 mg/ml streptomycin, 5610 25 M 2-ME) to remove adherent cells. Non-adherent cells were plated at a density of 5610 6 cells/dish, and cultivated for another five days in complete medium in the presence of GM-CSF (10% v/v). The cells were counted, plated in medium devoid of FCS and antibiotics and exposed to C. pneumoniae at a multiplicity of infection (MOI) of 5. After 30 hours the BMDC were counted and used for restimulation assays.
BMDM were generated according to Rutschman et al. [23] . Briefly, femora and tibiae of mice were rinsed with cell culture medium applied through a 26-gauge syringe. Bone marrow cells were cultured in petri dishes at a density of 5610 6 cells/dish in the presence of L cell-conditioned medium as a source of M-CSF-1 (10% v/v). The medium used was very low endotoxin DMEM (PAA Laboratories GmbH, Austria) supplemented with 10% FCS (Biochrom AG, Germany), 2-ME (50 mM; Life Technologies, Germany) and the antibiotics Vancomycin and Gentamicin, both provided by Sigma-Aldrich (Germany). Cells were washed vigorously and only adherent macrophages were used 6-7 days after plating. FACS analysis showed that these BMDM were F4/ 80 + and CD11b + as described previously (data not shown) [10] .
Isolation of lung and spleen cells
Mice were sacrificed with CO 2 on day 6, 9 or 12 post infection with C. pneumoniae. Lungs were flushed with 10 ml PBS and digested after manual mincing. The lungs were digested with collagenase VIII (400 U/100 ml 10 min at room temperature, 400 U/2 ml RPMI 0% FCS, 30 min at 37uC), washed and 
Determination of IFNc levels
IFNc levels were determined using a commercially available ELISA system (DuoKit BD Biosciences). The assay was performed according to manufacturer's manual. Data were analyzed using SigmaPlot 10.0 (Systat Software, Inc.).
Flow cytometry
Cells were counted and concentrated to 2610 6 cells per ml. Cells were washed with PBS (3% FCS) and pre-incubated with EMA (2 mg/ml, 20 min 4uC, Molecular Probes, OR, USA) to exclude dead cells and anti-CD16/32 (10 mg/ml, 10 min, 4uC, Caltag Laboratories, Invitrogen, Carlsbad, CA, USA) to block Fcreceptors. Cells were stained with different combinations of APCor PE-labelled mAb specific for CD3, APC-labelled mAb directed against CD8 (2 mg/ml, Caltag Laboratories) and PE-labelled mAb directed against CD4 (2 mg/ml, Caltag Laboratories) for 30 min on ice. The cells were washed again and then fixed and permeabilized with Perm/Wash (BD Biosciences, San Jose, CA, USA) for 20 min on ice. After another wash step intracellular staining was performed with FITC-labelled mAb directed against IFNc (1 mg/ml, BD) for 30 min on ice. Cells were washed with Perm/Wash (BD) twice and fixed again with 2% paraformaldehyde.
To detect regulatory CD4 + T-cells, cells were also stained with a mAb specific for CD25 (5 mg/ml, 30 min, 4uC, BD) and with a mAb specific for Foxp3 (clone FJK-16 s, eBioscience, Frankfurt, Germany) using the Foxp3 Staining Buffer Set from eBioscience (00-5523-00) according to the manufacturer's recommendations.
The induction of co-stimulatory molecules on CD11c + pulmonary cells was analyzed by staining the cells with antibodies specific for CD11c (2 mg/ml, Caltag Laboratories), CD80 (5 mg/ ml, BD), CD86 (2 mg/ml, BD) and MHC class II molecules I-A/I-E (5 mg/ml, BD).
Flow cytometry was performed with a Calibur instrument (BD Biosciences, San Jose, CA, USA), the data were analyzed using the FloJo software (Three Star Inc, OR, USA).
Cell lysis, SDS-PAGE and Western blotting
Cell extracts were prepared for Western blotting using RIPA buffer (20 mM Tris pH 7.5, 150 mM NaCl, 1% NP-40, 0,5% Sodium Deoxycholate, 1 mM EDTA, 0,1% SDS) which was supplemented with Sodium Orto-Vanadat (Sigma-Aldrich, Germany) and a protease inhibitor cocktail (Roche Diagnostics GmbH, Germany). Cell lysates were clarified by sonication and centrifugation before electrophoresis. Proteins were separated by SDS-PAGE (10% acrylamide) in TANK Buffer (25 mM Tris, 0.2 M glycine, 0.1% SDS), using Laemmli buffer (62.5 mM Tris, 50% glycerol, 2% SDS, 2 mM EDTA) for sample loading. After transfer to nitrocellulose membrane by semidry electroblotting for 1.5 h (2 mA/cm 2 ) in Transfer Buffer (25 mM Tris, 250 mM Glycine, 20% Methanol, 0,35% SDS), membranes were blocked in TBST (2.4 g/l Tris, 8 g/l NaCl, 0.1% Tween, pH 7.6, containing 5% milk powder, 2 h, room temperature). Thereafter, membranes were incubated with antibodies specific for iNOS (diluted 1:1000), IRF-1 (diluted 1:500), IkB (diluted 1:5000) and bactin (diluted 1:20000). All primary antibodies were incubated overnight at 4uC. After three washing steps with TBST the secondary antibody was added (diluted 1:8000 in TBST containing 5% milk powder, 2 h, room temperature). The blot was washed again three times with TBST and visualized using the Western lightning TM -Chemiluminiscence Reagent (Perkin Elmer LAS Inc, MA, USA) as described by the manufacturer.
Nitrite measurement
Nitrite production was measured from wild type and TLR2/4 double-deficient BMDM supernatants. Briefly, the cells were cultured in 12-well plates in 1 ml of culture medium until confluence. The cells were stimulated with IFNc or C. pneumoniae and the culture supernatants were collected. Nitrite was measured by adding 50 ml of Griess reagent (1% sulfanilamide and 0.1% naphthylethylenediamide in 5% phosphoric acid) to 50 ml samples of culture medium. The optical density at 550 nm (OD 550 ) was measured using a microplate reader and the nitrite concentration calculated by comparison with the OD 550 produced using standard solutions of sodium nitrite in the culture medium.
Statistics
Comparison of two equally treated groups was analyzed by Mann-Whitney Rank sum test. More than two equally treated groups were tested for significant differences with one way ANOVA, post hoc test Holm-Sidak. Statistical analysis was performed with SigmaStat (SPSS Inc., IL, USA). Figure S1 Identification of TLR2/4 double-deficient mice. Genomic tail DNA was prepared from 19 mice bred from a cross of TLR2-or TLR4-deficient mice. Primer sequences used were as follows: TLR2 WT1 59-CTTCCTGAATTTGTCCAG-TACAGG-39 TLR2 WT2 59-TCGACCTCGATCAACAGGA-GAAGGG-39 TLR2 KO 59-GGGCCAGCTCATTCCTCCC-ACTCAT-39 TLR4 WT1 59-GTTTAGAGAATCTGGTGGC-TGTGGAGAC-39 TLR4 WT2 59-TATATG CGGCCGCT-CATCTGC TGTACTTTTTACAGCC-39 TLR4 KO59-TGT-TGGGTCGTTTGTTCGGATCCGTCG-39. PCR amplification using primers TLR2 WT1 and TLR2 WT2, or TLR2 WT1 and TLR2 KO, or TLR4 WT1 and TLR4 WT2, or TLR4 WT1 and TLR4 KO detected the wild type TLR2 gene, TLR2-deficiency, the wild type TLR4 gene or TLR4-deficiency, respectively. The different PCRs were run with slight variations (details upon request): 94-95uC180-300 s 94-95uC 30-60 s 59-67uC 30-60 s30 cycles 70-74uC 60-180 s 72uC120 s 4uC. (TIF)
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